EPHA2 and neoplasm: Thus, ephrin-A5 could have been investigated as a potential tumor-suppressing ligand through the interaction with its tumor promoting receptors such as EPHA2, EPHA3, EPHA4, EPHA5, EPHA7, EPHA8, and EPHB2 in sarcomas [21].